|
Dominguez-Rodriguez A, Avanzas P, Consuegra-Sanchez L, Sanchez-Grande A, Abreu-Gonzalez P, Conesa-Zamora P. Inflammatory markers in blood and thrombus aspirated from patients with acute myocardial infarction with st-segment elevation: ARTERIA trial study design and rationale. Biomarkers. 2013 Jun;18(4):369-72. doi: 10.3109/1354750X.2013.797028. PubMed PMID: 23701265.
AÑO: 2013; IF: 1.73
|
|
Cano P, Consuegra-Sánchez L, Conesa P, Torres-Moreno D, Jaulent L, Dau D, Picó F, Villegas M. [Relevance of CYP2C19 2 regarding platelet reactivity in patients with acute coronary syndrome treated with clopidogrel]. Med Clin (Barc). 2014 Jul 7;143(1):6-12. doi: 10.1016/j.medcli.2013.04.042. Spanish. PubMed PMID: 23850044.
AÑO: 2014; IF: 1.417
|
|
Gutiérrez-Cívicos R, Hurtado AM, Torres-Moreno D, Sanchez-Blanco JJ, Español I, Consuegra-Sánchez L, Perez-Ceballos E, Gutiérrez-Meca MD, Jerez A, Conesa-Zamora P. Rituximab response in follicular lymphoma is associated with the rs20575 polymorphism in TRAILR1 extrinsic apoptosis trigger. Pharmacogenet Genomics. 2017 Feb;27(2):70-77. doi: 10.1097/FPC.0000000000000262. PubMed PMID: 27977511.
AÑO: 2017; IF: 2.25
|
|
Gutiérrez-Cívicos R, Hurtado AM, Torres-Moreno D, Sanchez-Blanco JJ, Español I, Consuegra-Sánchez L, Perez-Ceballos E, Gutiérrez-Meca MD, Jerez A, Conesa-Zamora P. A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients. Am J Hematol. 2016 Jun;91(6):E305-7. doi: 10.1002/ajh.24354. Epub 2016 Apr 24. PubMed PMID: 26950187.
AÑO: 2016; IF: 5.275
|
|
Dominguez-Rodriguez A, Abreu-Gonzalez P, Consuegra-Sanchez L, Avanzas P, Sanchez-Grande A, Conesa-Zamora P. Thrombus Aspirated from Patients with ST-Elevation Myocardial Infarction: Association between 3-Nitrotyrosine and Inflammatory Markers - Insights from ARTERIA Study. Int J Med Sci. 2016 Jun 18;13(7):477-82. doi: 10.7150/ijms.15463. eCollection 2016. PubMed PMID: 27429583; PubMed Central PMCID: PMC4946117.
AÑO: 2016; IF: 2.399
|
23701265